BGLC: BioNexus Gene Lab Corp Common stock Company Profile & Statistics

About

BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia.

Info & Links

CEO

Su-Leng Tan Lee

Headquarters

28-A-28-7 TOWER A,MENARA UOA BANGSAR,N0.5 JLN BANSAR UTAMA 1
KUALA LUMPUR, N8 59200, MALAYSIA

Auditor

JP CENTURION & PARTNERS PLT

Share holders

301

Employees

BioNexus Gene Lab Corp Common stock Statistics

Valuation Measures

Market Capitalization²

5.08M

Enterprise Value

3.55M

Enterprise Value/EBITDA(ttm)

-2.50

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.66

Price to Book(mrq)

0.65

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

13.65%

Operating Margin(ttm)

-10.17%

Profit Margin(ttm)

-14.81%

Return on Equity(ttm)

-9.93%

Return on Invested Capital(ttm)

-17.54%

Return on Assets(ttm)

-8.43%

Income Statement

Revenue(ttm)

9.51M

Revenue Per Share(ttm)

0.53

Gross Profit(ttm)

1.29M

EBITDA(ttm)³

-1.42M

Net Income Available to Common(ttm)

-1.60M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

5.79

52-Week Change

-52.44%

S&P 500 52-Week Change

9.00%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

17.97M

Dividend Yield

0.00%

Float⁴

17.61M

% Held by Insiders

2.02%

% Held by Institutions

18.85%

Balance Sheet

Total Cash(mrq)

4.38M

Total Cash Per Share(mrq)

0.24

Total Debt(mrq)

50.80K

Total Debt/Equity(mrq)

0.61%

Current Ratio(mrq)

3.81%

Quick Ratio(mrq)

3.99%

Book Value Per Share(mrq)

0.46

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.13

Free Cash Flow(ytd)

-2.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BGLC

BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp Common stock Profile